KHALI

SHARED STORY

Loading story



Get Khali



Open in app

Free on the App Store

#root { display: none !important; } html, body { height: auto !important; } body { overflow: auto !important; margin: 0; background: #07111f; color: #f4f4f5; font: 16px/1.6 system-ui, sans-serif; } article { box-sizing: border-box; max-width: 760px; margin: 0 auto; padding: 48px 24px 72px; } h1 { font-size: clamp(2rem, 7vw, 3.5rem); line-height: 1.05; } h2 { margin-top: 2rem; } a { color: #64b5ff; }

technology · 2 outlets · 2 linked reports

GLP-1 Weight-Loss Pills Take Off With 170,000 Prescriptions

2026-07-06

AI-assisted: summaries and questions may be incomplete or incorrect. Verify important details with the linked original reporting.

Summary

By July 5, 2026, newly approved oral GLP-1 weight-loss pills had been prescribed to about 170,000 people, outpacing earlier injectable adoption.
In Novo Nordisk trials, pill users lost an average of 13% of body weight over 64 weeks alongside diet and exercise.
A separate study offered the first clinical evidence that semaglutide drugs may slow processes tied to biological aging.

The question

Oral GLP-1 pills will make weight-loss medication mainstream.

Original reporting

Open this story in Khali

Get Khali on the App Store